Literature DB >> 32865335

Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK.

Mikalah U Thomas1, Justin K Messex2, Tu Dang2, Sarki A Abdulkadir3,4,5, Cheryl L Jorcyk6, Geou-Yarh Liou1,2.   

Abstract

The risk factors for prostate cancer include a high-fat diet and obesity, both of which are associated with an altered cell environment including increased inflammation. It has been shown that chronic inflammation due to a high-fat diet or bacterial infection has the potential to accelerate prostate cancer as well as its precursor, prostatic intraepithelial neoplasia (PIN), development. However, the underlying mechanism of how chronic inflammation promotes prostate cancer development, especially PIN, remains unclear. In this study, we showed that more macrophages were present in PIN areas as compared to the normal areas of human prostate. When co-culturing PIN cells with macrophages in 3D, more PIN cells had nuclear localized cyclin D1, indicating that macrophages enhanced PIN cell proliferation. We identified ICAM-1 and CCL2 as chemoattractants expressed by PIN cells to recruit macrophages. Furthermore, we discovered that macrophage-secreted cytokines including C5a, CXCL1, and CCL2 were responsible for increased PIN cell proliferation. These three cytokines activated ERK and JNK signaling in PIN cells through a ligand-receptor interaction. However, only blockade of ERK abolished macrophage cytokines-induced cell proliferation of PIN. Overall, our results provide a mechanistic view on how macrophages activated through chronic inflammation can expedite PIN progression during prostate cancer development. The information from our work can facilitate a comprehensive understanding of prostate cancer development, which is required for improvement of current strategies for prostate cancer therapy.
© 2020 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  C5a; CCL2; cell growth; macrophage; prostate intraepithelial neoplasia

Mesh:

Substances:

Year:  2020        PMID: 32865335      PMCID: PMC7914274          DOI: 10.1111/febs.15541

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  72 in total

1.  A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells.

Authors:  A Smith; F Ramos-Morales; A Ashworth; M Collins
Journal:  Curr Biol       Date:  1997-11-01       Impact factor: 10.834

2.  CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts.

Authors:  Oliver Dewald; Pawel Zymek; Kim Winkelmann; Anna Koerting; Guofeng Ren; Tareq Abou-Khamis; Lloyd H Michael; Barrett J Rollins; Mark L Entman; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2005-03-17       Impact factor: 17.367

3.  Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner.

Authors:  Liat Izhak; Gizi Wildbaum; Uri Weinberg; Weinberg Uri; Yuval Shaked; Jennifer Alami; Daniel Dumont; Boris Friedman; Avi Stein; Nathan Karin
Journal:  J Immunol       Date:  2009-12-07       Impact factor: 5.422

4.  Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma.

Authors:  L Mazzucchelli; P Loetscher; A Kappeler; M Uguccioni; M Baggiolini; J A Laissue; C Mueller
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

5.  CCL2 is a potent regulator of prostate cancer cell migration and proliferation.

Authors:  Robert D Loberg; LaShon L Day; Jason Harwood; Chi Ying; Lauren N St John; Ryan Giles; Chris K Neeley; Kenneth J Pienta
Journal:  Neoplasia       Date:  2006-07       Impact factor: 5.715

6.  Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate.

Authors:  Tomomi Fujii; Keiji Shimada; Osamu Asai; Nobumichi Tanaka; Kiyohide Fujimoto; Kazuya Hirao; Noboru Konishi
Journal:  Pathobiology       Date:  2013-01-11       Impact factor: 4.342

Review 7.  Monocyte chemoattractant protein-1 (MCP-1): an overview.

Authors:  Satish L Deshmane; Sergey Kremlev; Shohreh Amini; Bassel E Sawaya
Journal:  J Interferon Cytokine Res       Date:  2009-06       Impact factor: 2.607

8.  Morphoproteomic confirmation of a constitutively activated mTOR pathway in high grade prostatic intraepithelial neoplasia and prostate cancer.

Authors:  Robert E Brown; George Zotalis; Ping L Zhang; Bihong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

9.  Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin.

Authors:  Oh-Joon Kwon; Li Zhang; Michael M Ittmann; Li Xin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

Review 10.  Targeting the CCL2-CCR2 signaling axis in cancer metastasis.

Authors:  Su Yin Lim; Arseniy E Yuzhalin; Alex N Gordon-Weeks; Ruth J Muschel
Journal:  Oncotarget       Date:  2016-05-10
View more
  4 in total

1.  Macrophages Cytokine Spp1 Increases Growth of Prostate Intraepithelial Neoplasia to Promote Prostate Tumor Progression.

Authors:  Justin K Messex; Crystal J Byrd; Mikalah U Thomas; Geou-Yarh Liou
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

2.  Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study.

Authors:  Sonia Fantone; Giovanni Tossetta; Rodolfo Montironi; Martina Senzacqua; Daniela Marzioni; Roberta Mazzucchelli
Journal:  Eur J Histochem       Date:  2020-10-19       Impact factor: 3.188

3.  GSTT1, an increased risk factor for prostate cancer in patients with metabolic syndrome.

Authors:  Dongdong Liu; Bangwei Che; Pan Chen; Jun He; Yi Mu; Kehang Chen; Wenjun Zhang; Shenghan Xu; Kaifa Tang
Journal:  J Clin Lab Anal       Date:  2022-03-15       Impact factor: 2.352

Review 4.  Prostate Microbiota and Prostate Cancer: A New Trend in Treatment.

Authors:  Bangwei Che; Wenjun Zhang; Shenghan Xu; Jingju Yin; Jun He; Tao Huang; Wei Li; Ying Yu; Kaifa Tang
Journal:  Front Oncol       Date:  2021-12-10       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.